Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.